Digital Pharma Supply Chain Management Improves Data Access

PCI | bridge – a digital pharma supply chain management system; making real-time inventory, production, distribution, and shipping information readily accessible.

Published in PharmTech March 2021

Digital Pharma Supply Chain Management pci | bridge

PCI Pharma Services, a contract development and manufacturing organization (CDMO), introduced the pci | bridge digital platform in September 2020 to make real-time inventory, production, distribution, and shipping information readily accessible to its biopharmaceutical clients. “The pharma supply chain management platform includes data for raw materials received, as well as bulk materials, storage-only products, and finished goods,” explains Morgan Brandt, director of Digital Products at PCI Pharma Services.

The goal of pci | bridge is to not only make clients’ lives easier, but to help them get life-changing therapies to patients faster by providing efficiencies via greater transparency, accessibility, and automated communications,” says Brandt. She notes that clients appreciate the “self-serve” aspect of the platform and the customized reports. Insights from data help clients make more informed decisions.

The platform is part of PCI’s digital transformation strategy. The pharma supply chain management system enables the digitization of records by providing a document repository where electronic paperwork can be stored and accessed in one place, with signatures secured on the platform. Brandt says that cybersecurity was a focus during the development of the platform and that cloud-based storage helps ensure data integrity.

We provide a complete range of pharma supply chain management services and we are committed to supporting clients at every stage of the clinical cycle, delivering best-in-class services efficiently and effectively.

Find out more about PCI | bridge here

Our dedicated team of specialists will be happy to discuss any of your supply chain management service needs. Contact us on +1 779-208-1819 (US) or +44 1495 711 222 (UK/EU) or email